These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28026951)
1. Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment. Mei L; Liu Y; Xia C; Zhou Y; Zhang Z; He Q Mol Pharm; 2017 Feb; 14(2):513-522. PubMed ID: 28026951 [TBL] [Abstract][Full Text] [Related]
2. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles. Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790 [TBL] [Abstract][Full Text] [Related]
4. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy. Sun H; Cao D; Wu H; Liu H; Ke X; Ci T Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771 [TBL] [Abstract][Full Text] [Related]
5. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours. Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485 [TBL] [Abstract][Full Text] [Related]
6. Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug. Mei L; Liu Y; Zhang H; Zhang Z; Gao H; He Q ACS Appl Mater Interfaces; 2016 Apr; 8(15):9577-89. PubMed ID: 27058058 [TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer. Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded micelles of amphiphilic diblock copolymer with pendant dendron improve antitumor efficacy: In vitro and in vivo studies. Voon SH; Kue CS; Imae T; Saw WS; Lee HB; Kiew LV; Chung LY; Yusa SI Int J Pharm; 2017 Dec; 534(1-2):136-143. PubMed ID: 29031979 [TBL] [Abstract][Full Text] [Related]
9. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
10. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin. Du H; Liu M; Yu A; Ji J; Zhai G Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815 [TBL] [Abstract][Full Text] [Related]
11. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis. Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867 [TBL] [Abstract][Full Text] [Related]
12. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models. Shamay Y; Golan M; Tyomkin D; David A J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892 [TBL] [Abstract][Full Text] [Related]
13. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. She W; Li N; Luo K; Guo C; Wang G; Geng Y; Gu Z Biomaterials; 2013 Mar; 34(9):2252-64. PubMed ID: 23298778 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
15. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation. Zhu B; Zhang H; Yu L Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291 [TBL] [Abstract][Full Text] [Related]
16. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent. Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates. Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207 [TBL] [Abstract][Full Text] [Related]
19. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472 [TBL] [Abstract][Full Text] [Related]
20. Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery. Han S; Li M; Liu X; Gao H; Wu Y Colloids Surf B Biointerfaces; 2013 Feb; 102():833-41. PubMed ID: 23107962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]